OrganiGram Holdings, Inc. (OGRMF)

organigram_logoOrganiGram Holdings, Inc is a Canadian company that develops, produces, and sells condition-specific medicinal marijuana. A licensed producer under Canada’s Marihuana for Medical Purposes Regulations (MMPR), the company currently has 16 strains of medical cannabis in production, and it is developing more.

Condition-specific marijuana means that it targets particular health conditions with a specific formulation using THC and/or CBD, which are the plant’s principal medicinal ingredients. Such treatment can be used for the symptoms or side-effects in patients with HIV/AIDS, cancer, anxiety, muscular dystrophy, spinal cord disease, arthritis, and many others.

OrganiGram’s marijuana strains are grouped into the following: stimulating appetite and controlling nausea (ACN); anxiety and stress disorders (ASD) including PTSD; managing chronic pain (MCP) using marijuana’s analgesic effects; neurological disorders and spasticity (NDS); and dignity, comfort, and quality of life (DCQ) for terminal illnesses and end-of-life care.

OrganiGram markets its products to both patients and doctors interested in medical cannabis. The company sells the products through telephone orders and online stores. In September 2014, it made its first shipment of medical marijuana products to registered and shortlisted customers.

The company was founded as Inform Exploration Corp in 2010. At that time, it was based in Vancouver and engaged in the acquisition and exploration of resource properties. It then became OrganiGram Holdings, Inc only in August 2014, following a reverse takeover.

Today, OrganiGram Holdings, Inc is based in New Brunswick. It is listed in the TSX Venture Exchange under the ticker symbol OGI, and in the US OTC markets under the symbol OGRMF. It has a market value pegged at USD 64.9 M. The company’s top-level executives include Denis Arsenault, Chairman, CEO, and President; Scott Franklin, CFO; and Brett Allan, Director of Investor Relations.

Yahoo! Finance: OGRMF News

Latest Financial News for OGRMF

Organigram fulfills gap in Canadian CBD Market with Edison CBD Oil

MONCTON, NB , May 29, 2019 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OGI.V), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce it has recently shipped more than one hundred and thirty thousand units of pure cannabidiol (CBD) oil destined for markets across Canada . The recent legalization of adult-use, recreational cannabis in Canada has resulted in an increased demand for CBD, a naturally occurring compound in cannabis which has no psychoactive effect.

The Blooming Weed Industry Explained In Charts And Maps: Storefronts And Deliveries By The Numbers

Many who want to get marijuana legally turn to Weedmaps ($WEEDMAPS), a user-generated-content website "where businesses and consumers can search and discover cannabis products" among other services it offers. In layman's terms, it is the Google Maps of weed. It's the legitimate, web version of asking a friend who knows a guy who knows a guy's cousin who might sell marijuana. For the sake of breaking down the weed industry in our own backyard, let's take a deeper dive into how many places one could get marijuana by doing a quick search on this website.

Investing $1,000 in HEXO, OrganiGram, and Aleafia 2 Years Ago Is Worth This Much Today

Small-cap cannabis growers have really been delivering the green in recent years.

Cannastocks2019 Investor Conference & Webinar Now Available for On-Demand Viewing

Individual and institutional investors as well as advisors are invited to log-on to to view presentations NEW YORK , May 17, 2019 /PRNewswire/ -- Virtual Investor Conferences, ...

Organigram Announces May 21st as Inaugural Date of Trading on the Nasdaq Global Select Market

MONCTON , May 17, 2019 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce that its common shares will commence trading on the Nasdaq Global Select Market under the symbol "OGI" on Tuesday May 21, 2019 . Organigram's common shares will continue to be listed and trade on the Toronto Venture Exchange (TSXV), also under the symbol "OGI".